Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (41)
  • 2024 (33)
  • 2023 (40)
  • 2022 (40)
  • 2021 (44)
  • 2020 (28)
  • 2019 (20)
  • 2018 (14)
  • 2017 (1)

Subject

  • Drug Trafficking (4010)
  • Synthetic drugs (1064)
  • Guns/Weapons (989)
  • OCDETF/Task Force (810)
  • Fake Pills (654)
  • Arrests/Convictions - Major (603)
  • Guilty Plea (529)
  • Seizures (Drugs/Property) (456)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (267)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (230)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Other (8)
  • Campaigns (7)
  • Critical Incident (6)
  • Counterfeit Pills (5)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Take Back Day (246)
  • Congressional Affairs (15)

Drug Name

  • Oxycodone (6)
  • Opioids (4)
  • Synthetic Opioids (4)
  • Fentanyl (2)
  • Heroin (2)
  • Hydromorphone (2)
  • Barbiturates (1)
  • Methamphetamine (1)

Field Division

  • Sede (38)
  • Seattle (25)
  • Omaha (21)
  • Phoenix (17)
  • Louisville (16)
  • El Paso (13)
  • Miami (12)
  • Rocky Mountain (12)
  • St. Louis (12)
  • Atlanta (11)
  • New Orleans (11)
  • Washington, DC (10)
  • Chicago (9)
  • New Jersey (9)
  • San Diego (9)
  • Philadelphia (8)
  • New York (7)
  • Houston (5)
  • San Francisco (5)
  • Dallas (3)
  • Los Angeles (3)
  • New England (3)
  • Detroit (1)
Clear All Results
PRESS RELEASE

DEA Omaha Division collects 32,713 pounds of unwanted medication at spring Take Back Day event

Mayo 08, 2019
OMAHA, Neb.,– The United States Drug Enforcement Administration collected nearly 469 tons of unwanted medication at the 17th National Prescription Drug Take Back Day event, April 27, with a record-setting 6,398 sites hosted by more than 5,000 law enforcement partners. In Nebraska, 5,661 pounds of potentially dangerous and unwanted drugs...
Mayo 08, 2019
PRESS RELEASE

DEA’s 17th National Prescription Drug Take Back Day has highest-ever partner participation

Mayo 06, 2019
SAN DIEGO and IMPERIAL, Calif. – With enthusiastic participation nationwide, DEA and its law enforcement partners have now collected nearly 12 million pounds of unused or expired prescription medications over the course of 17 successful DEA National Prescription Drug Take Back events. During the 17th semiannual event on April 27...
Mayo 06, 2019
PRESS RELEASE

DEA announces 17th National Drug Take Back

Abril 23, 2019
PHOENIX – DEA announces the 17th National Prescription Drug Take Back will be held April 27, from 10:00 a.m. to 2:00 p.m. local time. Sites will be set up throughout communities nationwide so local residents can anonymously return their unwanted, unneeded or expired prescription drugs for safe disposal. (DEA cannot...
Abril 23, 2019
PRESS RELEASE

Fentanyl and heroin darknet vendors indicted

Abril 05, 2019
SACRAMENTO, Calif. — A Rancho Cordova woman was indicted on April 4, 2019, charged with distribution of fentanyl and oxycodone and other opioids as a result of a coordinated operation by the U.S. Attorney’s Office, the Federal Bureau of Investigation, Homeland Security Investigations, the Drug Enforcement Administration and the U.S...
Abril 05, 2019
PRESS RELEASE

DEA announces enhanced tool for registered drug manufacturers and distributors to combat opioid crisis

Febrero 26, 2019
WASHINGTON – The Drug Enforcement Administration today announced the launch of an enhanced system to help more than 1,500 registered drug manufacturers and distributors nationwide more effectively identify potential illicit drug diversion and combat the opioid epidemic. On Oct. 24, 2018, President Trump signed into law the “Substance Use–Disorder Prevention...
Febrero 26, 2019
PRESS RELEASE

Manhattan U.S. Attorney announces extradition of OFAC- sanctioned Afghan man for Narco-Terrorism offenses

Febrero 07, 2019
NEW YORK - Christopher Tersigni, Special Agent in Charge of the United States Drug Enforcement Administration Special Operations Division and Geoffrey S. Berman, the United States Attorney for the Southern District of New York, announced today the extradition of Haji Abdul Satar Abdul Manaf, aka “Haji Abdul Sattar Barakzai,” for...
Febrero 07, 2019
PRESS RELEASE

DEA releases 2018 National Drug Threat Assessment

Noviembre 02, 2018
WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...
Noviembre 02, 2018
PRESS RELEASE

DEA achieves significant milestone during 16th National Prescription Drug Take Back Day

Noviembre 02, 2018
MIAMI – With the robust participation of Americans nationwide, DEA and its law enforcement partners have now surpassed its 10 million pound goal and collected nearly 11 million pounds of unused, unwanted or expired prescription medications over the course of 16 successful DEA National Prescription Drug Take Back events. During...
Noviembre 02, 2018
PRESS RELEASE

DEA and partners hold National Prescription Drug Take Back Day

Octubre 25, 2018
SEATTLE – This Saturday, October 27, from 10 a.m. to 2 p.m., (local time) the federal Drug Enforcement Administration DEA and its local law enforcement, community and tribal partners in the Pacific Northwest will collect expired, unused, and unwanted prescription medications at one of 209 collection sites. There are 19...
Octubre 25, 2018
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

Agosto 31, 2018
WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
Agosto 31, 2018
Showing 241 - 250 of 261 results

Paginación

  • Primera página «
  • Página anterior ‹
  • Página 19
  • Página 20
  • Página 21
  • Página 22
  • Página 23
  • Página 24
  • Current page 25
  • Página 26
  • Página 27
  • Siguiente página ›
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster